Literature DB >> 17174426

CARD15 variants in patients with sporadic Parkinson's disease.

Monika Bialecka1, Mateusz Kurzawski, Gabriela Klodowska-Duda, Grzegorz Opala, Stefania Juzwiak, Grzegorz Kurzawski, Eng-King Tan, Marek Drozdzik.   

Abstract

Recent reports have proven the importance of genetic factors and inflammation in the pathogenesis of sporadic Parkinson's disease (PD). In the current study, the frequency of CARD15/NOD2 gene variants (R702W, G908R, L1007fs), previously associated with Crohn's disease--a common inflammatory bowel disease, have been examined in a group of 308 sporadic PD patients and 220 healthy controls. Significantly higher frequency of total CARD15 variant alleles in PD patients (13.0%) compared to the controls (8.0%, p<0.02) was observed. 24.0% of PD patients carried at least one CARD15 variant allele compared to 15.5% of healthy controls (p<0.02, OR=1.73). The results of the study suggest, that the polymorphism in CARD15/NOD2 gene may be a risk factor for sporadic PD development, and support the concept of inflammatory pathogenesis of PD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17174426     DOI: 10.1016/j.neures.2006.11.012

Source DB:  PubMed          Journal:  Neurosci Res        ISSN: 0168-0102            Impact factor:   3.304


  24 in total

Review 1.  Neuroinflammatory mechanisms in Parkinson's disease: potential environmental triggers, pathways, and targets for early therapeutic intervention.

Authors:  Malú G Tansey; Melissa K McCoy; Tamy C Frank-Cannon
Journal:  Exp Neurol       Date:  2007-07-17       Impact factor: 5.330

2.  Bidirectional Neural Interaction Between Central Dopaminergic and Gut Lesions in Parkinson's Disease Models.

Authors:  Pablo Garrido-Gil; Ana I Rodriguez-Perez; Antonio Dominguez-Meijide; Maria J Guerra; Jose L Labandeira-Garcia
Journal:  Mol Neurobiol       Date:  2018-02-05       Impact factor: 5.590

3.  Stool Immune Profiles Evince Gastrointestinal Inflammation in Parkinson's Disease.

Authors:  Madelyn C Houser; Jianjun Chang; Stewart A Factor; Eric S Molho; Cyrus P Zabetian; Erin M Hill-Burns; Haydeh Payami; Vicki S Hertzberg; Malú G Tansey
Journal:  Mov Disord       Date:  2018-03-23       Impact factor: 10.338

Review 4.  Is Parkinson's disease a chronic low-grade inflammatory bowel disease?

Authors:  Malvyne Rolli-Derkinderen; Laurène Leclair-Visonneau; Arnaud Bourreille; Emmanuel Coron; Michel Neunlist; Pascal Derkinderen
Journal:  J Neurol       Date:  2019-04-12       Impact factor: 4.849

Review 5.  Parkinson's disease: an update on pathogenesis and treatment.

Authors:  Tom Foltynie; Joshua Kahan
Journal:  J Neurol       Date:  2013-04-16       Impact factor: 4.849

Review 6.  Brain-gut-microbiota axis in Parkinson's disease.

Authors:  Agata Mulak; Bruno Bonaz
Journal:  World J Gastroenterol       Date:  2015-10-07       Impact factor: 5.742

Review 7.  The role of inflammation in sporadic and familial Parkinson's disease.

Authors:  Michela Deleidi; Thomas Gasser
Journal:  Cell Mol Life Sci       Date:  2013-05-12       Impact factor: 9.261

Review 8.  Neuroinflammation in Parkinson's disease: its role in neuronal death and implications for therapeutic intervention.

Authors:  Malú G Tansey; Matthew S Goldberg
Journal:  Neurobiol Dis       Date:  2009-11-10       Impact factor: 5.996

9.  Parkin targets NOD2 to regulate astrocyte endoplasmic reticulum stress and inflammation.

Authors:  Komudi Singh; Kim Han; Sharada Tilve; Kaiyuan Wu; Herbert M Geller; Michael N Sack
Journal:  Glia       Date:  2018-10-30       Impact factor: 7.452

Review 10.  The role of innate and adaptive immunity in Parkinson's disease.

Authors:  George T Kannarkat; Jeremy M Boss; Malú G Tansey
Journal:  J Parkinsons Dis       Date:  2013       Impact factor: 5.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.